Trial Profile
A trial evaluating the clinical outcomes of ticagrelor discontinuation in acute coronary syndrome patients following coronary artery bypass grafting surgery (CAPITAL Registry)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Oct 2016
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary)
- Indications Acute coronary syndromes
- Focus Adverse reactions
- 11 Feb 2016 New trial record